A key CDMO in the liquid formulations sector, Laboratoires Chemineau is pursuing a strategy of continuous innovation through a combination of major capacity-focused investments in aerosol and pump spray formats and the introduction of new ultra-clean, radiation-free processes for preservative-free liquid and semi-liquid aerosol formulations.
By strengthening its R&D teams through the arrival of David LAFARGUE, a doctor in biopolymer science, Laboratoires Chemineau is seeking to offer an even more innovative range of services by developing an innovative portfolio and promoting a culture of open innovation, and all with the aim of providing agile and pragmatic innovation for companies in the pharmaceutical industry.
For more informations, please contact : contact@chemineau.com